- Home
- VRNA vs GDS Comparison
VRNA vs GDS Comparison
Compare VRNA & GDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- GDS
- Stock Information
- Founded
- VRNA 2005
- GDS 2001
- Country
- VRNA United Kingdom
- GDS China
- Employees
- VRNA N/A
- GDS N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- GDS Computer Software: Programming Data Processing
- Sector
- VRNA Health Care
- GDS Technology
- Exchange
- VRNA Nasdaq
- GDS Nasdaq
- Market Cap
- VRNA 3.4B
- GDS 3.8B
- IPO Year
- VRNA 2017
- GDS 2016
- Fundamental
- Price
- VRNA $67.96
- GDS $44.76
- Analyst Decision
- VRNA Strong Buy
- GDS Buy
- Analyst Count
- VRNA 7
- GDS 5
- Target Price
- VRNA $57.14
- GDS $28.68
- AVG Volume (30 Days)
- VRNA 1.3M
- GDS 3.9M
- Earning Date
- VRNA 02-27-2025
- GDS 03-25-2025
- Dividend Yield
- VRNA N/A
- GDS N/A
- EPS Growth
- VRNA N/A
- GDS N/A
- EPS
- VRNA N/A
- GDS N/A
- Revenue
- VRNA $5,624,000.00
- GDS $1,564,750,016.00
- Revenue This Year
- VRNA N/A
- GDS $18.23
- Revenue Next Year
- VRNA $571.44
- GDS $12.76
- P/E Ratio
- VRNA N/A
- GDS N/A
- Revenue Growth
- VRNA 1127.95
- GDS 11.95
- 52 Week Low
- VRNA $11.39
- GDS $5.85
- 52 Week High
- VRNA $68.64
- GDS $52.50
- Technical
- Relative Strength Index (RSI)
- VRNA 76.88
- GDS 75.70
- Support Level
- VRNA $62.24
- GDS $32.85
- Resistance Level
- VRNA $65.50
- GDS $52.50
- Average True Range (ATR)
- VRNA 2.78
- GDS 3.24
- MACD
- VRNA 0.22
- GDS 1.89
- Stochastic Oscillator
- VRNA 94.86
- GDS 74.83
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About GDS GDS Holdings Limited ADS
GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. It has aggressively raised capital over the past four years for expansion. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.